Answers are grounded in this paper and cite their sources.
Clinical review reveals treatment dilemmas and transmission risks of disseminated histoplasmosis in pregnancy, highlighting the urgent need for maternal-fetal antifungal safety data.
Histoplasmosis is rarely diagnosed in pregnancy, though when disseminated it may infect the infant as well. Decisions regarding antifungal therapy in pregnant women can be difficult due to known toxicity risks and lack of rigorous study. Here we review the published literature regarding histoplasmosis in pregnancy as well as antifungal therapy in pregnancy and while lactating. We also bring our clinical experience with a disseminated histoplasmosis case affecting both mother and infant, as well as the mother’s perspective in her own words. “Sharing our story is important to me because I hope it can help others. The more information that exists about rare infections and treatments during pregnancy, the better doctors will be able to help families facing similar challenges.”
No takes yet. Share an insight, caveat, or question.
Kavalier et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: